Company
ProbiusDx
Moving bioanalysis from a reagent-centric to a data-centric approach
Also known as Probius, Probius DX, Inc.
- Status
- Operatingas of 2026-09-19
- Business model
- B2B
- Customers
- customers and partners
- Legal name
- Probius DX, Inc.
- probiusdx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Probius is a deep-tech company bridging the data gap between biology and AI, thereby illuminating new opportunities for the way biomedical research and healthcare are practiced.
Funding snapshot
- Total raised
- $2.4MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $2.4M2025-08-07
Funding rounds
- Round, 2025
- $2.4M2025-08-07, SEC form D sold, 21 investors
Products
- Hardware
- MiniQES Bioanalytical platform
Loading relationship preview